Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Clinical trial NCT02314156 · COMPLETED

Trial details

NCT number: NCT02314156
Sponsor: Northwestern University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

BRCA1 Mutation Carrier BRCA2 Mutation Carrier Ductal Breast Carcinoma In Situ Lobular Breast Carcinoma In Situ Stage 0 Breast Cancer Stage IA Breast Cancer Stage IB Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer

Start date: 2015-10-01
Primary completion: 2018-01-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.